Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $5.49B | $288.07M | $53.57M | $22.31M | $0.24 | 1,936.66% | 137.36% | N/A | N/A | |||
| SLNO | SOLENO THERAPEUTICS INC | $2.76B | $285.01M | $107.57M | $95.63M | $1.85 | N/A | N/A | N/A | N/A | |||
| CORT | CORCEPT THERAPEUTICS INC | $6.34B | $769.10M | -$6.87M | $46.67M | $0.46 | 12.20% | 17.73% | -63.78% | -11.76% | |||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $39.85B | $4.29B | $924.47M | $577.22M | $4.36 | 82.57% | 49.66% | N/A | N/A | |||
| HALO | HALOZYME THERAPEUTICS INC | $8.18B | $1.51B | $623.82M | $348.84M | $2.96 | 39.12% | 35.42% | -23.12% | 19.79% | |||
| KRYS | KRYSTAL BIOTECH INC | $8.90B | $417.30M | $213.96M | $225.03M | $7.75 | 25.15% | N/A | 79.40% | N/A | |||
| ADMA | ADMA BIOLOGICS INC | $1.98B | $509.86M | $221.54M | $165.35M | $0.69 | 10.99% | 60.37% | -21.59% | N/A | |||
| VCEL | VERICEL CORP | $1.81B | $292.09M | $40.42M | $21.46M | $0.43 | 22.45% | 17.20% | 760.00% | 33.87% | |||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $1.08B | $314.85M | $53.43M | $12.01M | $0.07 | 41.47% | 63.63% | N/A | N/A | |||
| RPRX | ROYALTY PHARMA PLC | $30.55B | $2.44B | $1.16B | $827.29M | $1.91 | 7.80% | 2.15% | -22.67% | 4.95% | |||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $9.70B | $3.24B | $482.49M | $268.74M | $1.40 | 9.90% | 11.94% | -49.09% | -20.32% | |||
| OMER | OMEROS CORP | $896.01M | $9.89M | $90.43M | $86.17M | $1.30 | N/A | N/A | N/A | N/A | |||
| ZVRA | ZEVRA THERAPEUTICS INC | $605.34M | $122.29M | $144.61M | $124.22M | $2.05 | 201.29% | 39.30% | N/A | N/A | |||
| ASND | ASCENDIS PHARMA A | $14.99B | $1.02B | $93.26M | $583.45M | $9.44 | 148.31% | 174.03% | N/A | N/A | |||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $15.00B | $4.44B | $675.03M | $29.49M | $0.47 | 9.20% | 12.75% | -93.97% | -44.94% | |||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $4.18B | $754.05M | $111.49M | $73.06M | $0.98 | 56.71% | N/A | N/A | N/A | |||
| LGND | LIGAND PHARMACEUTICALS INC | $4.36B | $274.48M | $225.55M | $153.56M | $7.90 | 51.24% | 8.15% | N/A | 26.70% | |||
| SPRO | SPERO THERAPEUTICS INC | $152.28M | $61.19M | $15.50M | $15.24M | $0.27 | 37.24% | 32.59% | N/A | N/A | |||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.82B | $899.11M | $236.96M | $145.62M | $2.53 | 20.71% | 35.13% | -5.24% | 51.21% | |||
| TECH | BIO-TECHNE CORP | $7.31B | $1.21B | $255.98M | $109.56M | $0.71 | 0.17% | 7.39% | -14.46% | -9.99% | |||
| TGTX | TG THERAPEUTICS INC | $6.09B | $700.35M | $150.00M | $461.90M | $3.22 | 81.26% | 278.04% | 1,092.59% | N/A | |||
| EXEL | EXELIXIS INC | $12.54B | $2.38B | $1.06B | $833.42M | $3.12 | 3.33% | 18.17% | 38.67% | 69.96% | |||
| UTHR | UNITED THERAPEUTICS CORP | $23.94B | $3.17B | $1.71B | $1.29B | $29.28 | 5.87% | 16.05% | 8.12% | 26.22% | |||
| NAGE | NIAGEN BIOSCIENCE INC | $298.67M | $130.42M | $21.24M | $18.64M | $0.24 | 20.84% | 16.96% | 33.33% | N/A | |||
| CPRX | CATALYST PHARMACEUTICALS INC | $3.82B | $596.96M | $334.94M | $221.32M | $1.81 | 11.65% | 37.80% | 9.70% | 21.27% | |||
| VRTX | VERTEX PHARMACEUTICALS INC | $109.25B | $12.22B | $5.39B | $4.34B | $17.01 | 10.08% | 13.75% | N/A | 9.84% | |||
| VCYT | VERACYTE INC | $3.61B | $541.74M | $115.05M | $88.01M | $1.11 | 16.91% | 34.50% | 158.14% | N/A | |||
| MDXG | MIMEDX GROUP INC | $564.50M | $389.42M | $54.47M | $30.70M | $0.21 | 10.51% | 9.58% | -22.22% | N/A | |||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $161.95M | $76.38M | $22.33M | $15.33M | $0.19 | 27.80% | 7.76% | 280.00% | N/A | |||
| REGN | REGENERON PHARMACEUTICALS INC | $68.12B | $14.92B | $5.74B | $4.42B | $42.56 | 5.92% | 10.16% | 1.89% | 2.53% | |||
| INCY | INCYTE CORP | $19.39B | $5.36B | $1.87B | $1.43B | $7.29 | 21.48% | 14.68% | 2,413.79% | 27.19% | |||
| SRPT | SAREPTA THERAPEUTICS INC | $1.81B | $2.18B | $82.73M | $65.06M | $0.60 | -2.20% | 30.67% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.